Clinical trials
Recruiting Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 19 |
| 2024 | 12 |
| 2025 | 10 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 5 |
| AstraZeneca | 3 |
| Xuzhou Medical University | 3 |
| AbbVie | 2 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Essen Biotech | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| M.D. Anderson Cancer Center | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| Affiliated Hospital of Nantong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 67 |
| Recurrence | 12 |
| Neoplasms, Plasma Cell | 8 |
| Leukemia, Myeloid, Acute | 6 |
| Neoplasms | 5 |
| Hematologic Neoplasms | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Blood Protein Disorders | 2 |
| Hematologic Diseases | 2 |
| Leukemia, Plasma Cell | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.